The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its legacy within the broader market now raises questions about long-term returns . Copycat versions are diminishing market share, leading to worries that investing in companies significantly dependent to Viagra's once-dominant influence could be a speculati